Jaguar Animal Health Inc (JAGX)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Dec 11, 2025 | MICEK, JOHN | Director | Stock Option (right to buy) | Acquisition | 7,377 | $0 |
| Dec 11, 2025 | JAYASURIYA, ANULA | Director | Stock Option (right to buy) | Acquisition | 5,870 | $0 |
| Dec 11, 2025 | LIZAK, CAROL R. | Chief Financial Officer | Common Stock | Acquisition | 11,740 | $0 |
| Dec 11, 2025 | SIEGEL, JONATHAN B. | Director | Stock Option (right to buy) | Acquisition | 7,377 | $0 |
| Dec 11, 2025 | BOCHNOWSKI, JAMES J | Director | Stock Option (right to buy) | Acquisition | 6,363 | $0 |
| Dec 11, 2025 | LIZAK, CAROL R. | Chief Financial Officer | Stock Option (right to buy) | Acquisition | 11,740 | $0 |
| Dec 11, 2025 | CONTE, LISA A | Director, See Remarks | Common Stock | Acquisition | 28,592 | $0 |
| Dec 11, 2025 | BOCHNOWSKI, JAMES J | Director | Common Stock | Acquisition | 6,363 | $0 |
| Dec 11, 2025 | KING, STEVEN R. | See Remarks | Common Stock | Acquisition | 11,740 | $0 |
| Dec 11, 2025 | CONTE, LISA A | Director, See Remarks | Stock Option (right to buy) | Acquisition | 28,592 | $0 |
| Dec 11, 2025 | CHATURVEDI, PRAVIN R | Chief Scientific Officer | Stock Option (right to buy) | Acquisition | 11,740 | $0 |
| Dec 11, 2025 | KING, STEVEN R. | See Remarks | Stock Option (right to buy) | Acquisition | 11,740 | $0 |
| Dec 11, 2025 | SIEGEL, JONATHAN B. | Director | Common Stock | Acquisition | 7,377 | $0 |
| Dec 11, 2025 | MICEK, JOHN | Director | Common Stock | Acquisition | 7,377 | $0 |
| Dec 11, 2025 | WOLIN, JONATHAN S. | See Remarks | Common Stock | Acquisition | 11,740 | $0 |
| Dec 11, 2025 | JAYASURIYA, ANULA | Director | Common Stock | Acquisition | 5,870 | $0 |
| Dec 11, 2025 | WOLIN, JONATHAN S. | See Remarks | Stock Option (right to buy) | Acquisition | 11,740 | $0 |
| Dec 11, 2025 | CHATURVEDI, PRAVIN R | Chief Scientific Officer | Common Stock | Acquisition | 11,740 | $0 |